Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1887-1894

  Hocquet, Didier ^a   Bertrand, Xavier ^a   Köhler, Thilo ^b   Talon, Daniel ^a   Plésiat, Patrick ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; APRAMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; FORTIMICIN; GENTAMICIN; IMIPENEM; ISEPAMICIN; KANAMYCIN; NEOMYCIN; NETILMICIN; PIPERACILLIN; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REPRESSOR PROTEIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BINDING SITE; CLONE; DNA SEQUENCE; EPIDEMIC; GENE; GENE MUTATION; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PHENOTYPIC VARIATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER PROTEINS; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FRANCE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; HUMANS; IMMUNOBLOTTING; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; POINT MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRESSOR PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0038102239     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1887-1894.2003     Document Type: Article

References (48)

1. Akasaka, T., Y. Onodera, M. Tanaka, and K. Sato. 1999. Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV. Antimicrob. Agents Chemother. 43:530-536.
2. Akasaka, T., M. Tanaka, A. Yamaguchi, and K. Sato. 2001. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob. Agents Chemother. 45:2263-2268.
3. Antibiogram Committee of the French Society for Microbiology. 1996. Technical recommendations for in vitro susceptibility testing. Clin. Microbiol. Infect. 2(Suppl. 1):S11-S25.
4. Babini, G. S., and D. M. Livermore. 2000. Are SHV β-lactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother. 44:2230.
5. Balows, A., W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy. 1991. Manual of clinical microbiology, 5th ed. ASM Press, Washington, D.C.
6. Beck-Sagué, C. M., S. N. Banerjee, and W. R. Jarvis. 1994. Epidemiology and control of Pseudomonas aeruginosa in U.S. hospitals, p. 51-71. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeruginosa: infections and treatment. Marcel Dekker, Inc., New York, N.Y.
7. Bert, F., C. Branger, and N. Lambert-Zechovsky. 2002. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.
8. Bertrand, X., P. Bailly, G. Blasco, P. Balvay, A. Boillot, and D. Talon. 2000. Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump. Clin. Infect. Dis. 31:E9-E14.
9. Bryan, L. E., and A. J. Godfrey. 1991. β-Lactam antibiotics: mode of action and bacterial resistance, p. 599-664. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
10. Chen, W. P., and T. T. Kuo. 1993. A simple and rapid method for the preparation of Gram-negative bacterial genomic DNA. Nucleic Acids Res. 21:2260.
11. Dubois, V., C. Arpin, M. Melon, B. Melon, C. André, C. Frigo, and C. Quentin. 2001. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of β-lactam resistance. J. Clin. Microbiol. 39:2072-2078.
12. Evans, K., L. Adewoye, and K. Poole. 2001. MexR repressor of the mexABoprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region. J. Bacteriol. 183:807-812.
13. Fish, D. N., S. C. Piscitelli, and L. H. Danziger. 1995. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15:279-291.
14. Frishman, D., and P. Argos. 1997. 75% accuracy in protein secondary structure prediction. Proteins 27:329-335.
15. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
16. Grattard, F., O. G. Gaudin, B. Pozzetto, A. Ros, and A. D. Mbida. 1993. Genotypic homogeneity of nosocomial Pseudomonas aeruginosa O12 strains demonstrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns. Eur. J. Clin. Microbiol. Infect. Dis. 12:57-61.
17. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. W. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
18. Hocquet, D., C. Vogne, F. El Garch, A. Vejux, N. Gotoh, A. Lee, O. Lomovskaya, and P. Plésiat. 2003. MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47:1371-1375.
19. Köhler, T., M. Michéa Hamzehpour, U. Henze, N. Gotoh, L. Kocjancic Curty, and J. C. Pechère. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.
20. Kureishi, A., J. M. Diver, B. Beckthold, T. Schollaardt, and L. E. Bryan. 1994. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother. 38:1944-1952.
21. Li, X. Z., D. Ma, D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 38:1742-1752.
22. Livermore, D. M., and Y. Y. Yang. 1987. β-Lactamase lability and inducer power of newer β-lactam antibiotics in relation to their activity against β-lactamase-inducibility mutants of Pseudomonas aeruginosa. J. Infect. Dis. 155:775-782.
23. Lomovskaya, O., A. Lee, K. Hoshino, H. Ishida, A. Mistry, M. S. Warren, E. Boyer, S. Chamberland, and V. J. Lee. 1999. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346.
24. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2242-2246.
25. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
26. Medeiros, A. A., and J. Crellin. 2000. Evaluation of the Sirscan automated zone reader in a clinical microbiology laboratory. J. Clin. Microbiol. 38:1688-1693.
27. Mellencamp, M. A., J. S. Roccaforte, L. C. Preheim, C. C. Sanders, C. A. Anene, and M. J. Bittner. 1990. Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production. Eur. J. Clin. Microbiol. Infect. Dis. 9:827-830.
28. Mouneimné, H., J. Robert, V. Jarlier, and E. Cambau. 1999. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:62-66.
29. Nakae, T., A. Nakajima, T. Ono, K. Saito, and H. Yoneyama. 1999. Resistance to β-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and β-lactamase. Antimicrob. Agents Chemother. 43:1301-1303.
30. Nakano, M., T. Deguchi, T. Kawamura, M. Yasuda, M. Kimura, Y. Okano, and Y. Kawada. 1997. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2289-2291.
31. Pai, H., J. W. Kim, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45:480-484.
32. Panzig, B., G. Schröder, F.-A. Pitten, and M. Gründling. 1999. A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany. J. Antimicrob. Chemother. 43:415-418.
33. Pellegrino, F. L., L. M. Teixeira, M. G. Siqueira Carvalho, S. Aranha Nouér, M. Pinto de Oliveira, J. L. Mello Sampaio, A. D'Avila Freitas, A. L. P. Ferreira, E. L. T. Amorim, L. W. Riley, and B. M. Moreira. 2002. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeira, Brazil. J. Clin. Microbiol. 40:2420-2424.
34. Pitt, T. L., D. M. Livermore, D. Pitcher, A. C. Vatopoulos, and N. J. Legakis. 1989. Multiresistant serotype O12 Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiol. Infect. 103:565-576.
35. Plésiat, P., J. Ramos Aires, C. Godard, and T. Köhler. 1997. Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. J. Bacteriol. 179:7004-7010.
36. Poole, K., N. Gotoh, H. Tsujimoto, Q. X. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. I. Yamagishi, X. Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724.
37. Poole, K., D. E. Heinrichs, and S. Neshat. 1993. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa regulation by iron and possible involvement in the secretion of the siderophore pyoverdine. Mol. Microbiol. 10:529-544.
38. Poole, K., K. Tetro, Q. X. Zhao, S. Neshat, D. E. Heinrichs, and N. Bianco. 1996. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40:2021-2028.
39. Ramos Aires, J., T. Köhler, H. Nikaido, and P. Plésiat. 1999. Involvement of an efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
40. Saito, K., H. Yoneyama, and T. Nakae. 1999. nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. FEMS Microbiol. Lett. 179:67-72.
41. Smith, A. W., and B. H. Iglewski. 1989. Transformation of Pseudomonas aeruginosa by electroporation. Nucleic Acids Res. 17:10509.
42. Srikumar, R., C. J. Paul, and K. Poole. 2000. Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 182:1410-1414.
43. Talon, D., V. Cailleaux, M. Thouverez, and Y. Michel-Briand. 1996. Discriminatory power and usefullness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J. Hosp. Infect. 32:135-145.
44. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
45. Trias, J., and H. Nikaido. 1990. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrobiol. Agents Chemother. 34:52-57.
46. Westbrock-Wadman, S., D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu, P. Warrener, L. Y. Nguyen, R. M. Shawar, K. R. Folger, and C. K. Stover. 1999. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983.
47. Zhao, Q., X. Z. Li, R. Srikumar, and K. Poole. 1998. Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob. Agents Chemother. 42:1682-1688.
48. Ziha-Zarifi, I., C. Llanes, T. Köhler, J. C. Pechère, and P. Plésiat. 1999. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43:287-291.